CPMD vs PFE: Which Stock is Better?
Side-by-side comparison of Cannapharmarx, Inc. and Pfizer Inc in 2026
CPMD
Cannapharmarx, Inc.
$0.00
PFE
Pfizer Inc
$27.05
Key Metrics Comparison
| Metric | CPMD | PFE | Winner |
|---|---|---|---|
| Market Cap | $3.25M | $153.81B | PFE |
| P/E Ratio | N/A | 19.60 | PFE |
| EPS (TTM) | $N/A | $1.38 | PFE |
| Revenue Growth | 1.1% | -0.0% | CPMD |
| Gross Margin | -192.1% | 75.8% | PFE |
Analyze CPMD
Full quant analysis
Analyze PFE
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is CPMD or PFE a better investment?
Comparing CPMD and PFE: Cannapharmarx, Inc. has a market cap of $3.25M while Pfizer Inc has $153.81B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between CPMD and PFE?
CPMD (Cannapharmarx, Inc.) and PFE (Pfizer Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: CPMD or PFE?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: CPMD or PFE?
CPMD has higher revenue growth at 1.1% vs -0.0% for PFE.
Which company is more profitable: CPMD or PFE?
Pfizer Inc (PFE) has higher gross margins at 75.8% compared to -192.1% for CPMD.
Which is the larger company: CPMD or PFE?
Pfizer Inc (PFE) is larger with a market cap of $153.81B compared to $3.25M for CPMD.
Should I buy CPMD or PFE in 2026?
Both CPMD and PFE have investment merit. CPMD trades at $0.00 while PFE trades at $27.05. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between CPMD and PFE stock?
Key differences: Market Cap ($3.25M vs $153.81B), P/E Ratio (N/A vs 19.6x), Revenue Growth (1.1% vs -0.0%), Gross Margin (-192.1% vs 75.8%).